Haleon HLN
NYSE HLN
$9.92 +0.05 (+0.50%)
At close: Aug 20, 2026 · 11:58 AM UTC

Haleon (HLN) Long-Term Investments (2026)

Haleon (HLN) Long-Term Investments (2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Haleon 44.07 Bn 43.10 Bn - 92.58 Mn
2 Teva Pharmaceutical Industries 43.41 Bn 39.75 Bn 2.15 Bn -
3 Zoetis 31.83 Bn 30.15 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.77 Bn 22.97 Bn 5.10 Bn 63.23 Mn
5 United Therapeutics 22.27 Bn 19.61 Bn 683.80 Mn 1.14 Bn
6 Viatris 18.76 Bn 17.87 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.65 Bn 15.26 Bn 935.80 Mn 149.10 Mn
8 Elanco Animal Health 11.93 Bn 11.40 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.16 Bn 10.00 Bn - 60.00 Mn
10 Alkermes 8.20 Bn 7.55 Bn 397.90 Mn 35.05 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 92.58 Mn